R. Menendez (Valencia, Spain), M. Woodhead (Manchester, United Kingdom)
Mortality in patients with COPD due to community acquired pneumonia D. Snijders, M. van der Eerden, C. de Graaff, W. Boersma (Alkmaar, Netherlands)
| |
Inpatients with PSI III community-acquired pneumonia: are low or high risk patients? A. Cervera, E. Fernandez-Fabrellas, M. C. Aguar, J. Blanquer, F. Sanz, R. Blanquer (Valencia, Spain)
| |
Admission in CAP patients with low-risk PSI(I-II): the right decision? M. C. Aguar, E. Fernandez-Fabrellas, A. Cervera, J. Blanquer, F. Tatay, R. Blanquer, F. Sanz, M. L. Briones, A. L. Andreu (Valencia, Spain)
| |
Factors associated with legionellosis lethality: a web-based multicentric study D. Ochoa, F. Sanz, J. Cayla, J. Blanquer (Barcelona, Valencia, Spain)
| |
COPD is an independent risk factor for mortality in community acquired pneumonia J. Chalmers, A. Singanayagam, A. Hill (Edinburgh, United Kingdom)
| |
Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP) S. Aliberti, A. Amir, G. N. Brock, B. K. Moffett, P. Peyrani, M. Volpi, F. Blasi, J. A. Ramirez (Milan, Italy; Louisville, KY, United States Of America)
| |
The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study P. Fernandez, P. Jimenez, P. Peyrani, J. Ramirez (Santiago, Chile; Louisville, KY, United States Of America)
| |
Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) A. Amir, S. Aliberti, P. Peyrani, F. Arnold, M. Cirino, J. Ramirez (Louisville, KY, United States Of America)
| |